Australia Commercial Lead: TIL Therapy Launch

Iovance Biotherapeutics, Inc.; Sydney; On-site; AUD 250,000 - 380,000; Full time

Job summary

Iovance Biotherapeutics, Inc. seeks a Commercial Lead, Australia to establish and scale the Australian market for AMTAGVI and Proleukin.

You will own the commercial strategy, drive revenue and profitability, and lead the full sales cycle from market development to patient infusion. You will build executive relationships with treatment centres and authorities, ensure regulatory and quality standards, and coordinate cross-functionally to accelerate market access.

Qualifications

• Bachelor's degree or equivalent; MBA/postgraduate preferred.
• 12+ years in oncology/biotech commercial leadership; hospital experience preferred.
• Proven success launching pharmaceutical/biotech products at country/regional level.
• Demonstrated profit-and-loss ownership and delivery on revenue, expenses and profitability targets.
• End-to-end sales process leadership tied to patient treatment, administration or infusion.
• Strong forecasting, budgeting, analytics and performance management experience.
• Experience building market, commercial capability or country organization.
• Experience developing service lines in teaching hospitals; transplant/cell therapy exposure preferred.
• Cell therapy field knowledge including service-line operations, quality, labs and nursing.
• High clinical aptitude in oncology/immunotherapy with operational/commercial acumen.
• Executive presence and ability to influence senior stakeholders.
• Ability to manage competing priorities and lead in a matrix organization.
• Lead the Australian commercial organisation growth.

Responsibilities

• Own and lead the Australian commercialisation strategy, launch plan and ongoing business performance for AMTAGVI and Proleukin.
• Hold P&L accountability for Australian business including revenue, expenses, forecasts and profitability.
• Establish annual and long-range commercial plans aligned with global objectives.
• Lead full sales cycle across authorised treatment centres and referral networks.
• Achieve patient infusion, demand and revenue targets while complying with laws and policies.
• Build and manage the Australian commercial forecast using readiness, referrals, scheduling and revenue data.
• Develop relationships with treatment centres, authorities, funders and partners to expand TIL therapy.
• Lead treatment-centre authorisation process with risk-based tools and provide quality oversight.
• Lead cross-functional meetings to develop workflows and remove barriers to treatment.
• Develop and execute training for authorised users; ensure access to chain-of-identity systems.
• Lead cross-functional execution across Market Access, Finance, HR, Legal, Supply Chain and global teams.
• Represent Australia in global planning, forecasting and investment discussions.
• Design the future Australian commercial organisation and select/develop new team members.
• Participate in advisory boards to identify market-development needs; adhere to core values and policies.

Skills

Product launch experience

P&L ownership

End-to-end sales cycle

Forecasting

Budgeting

Business analytics

Performance management

Market development

Service lines development

Cell therapy knowledge

Oncology knowledge

Executive presence

Prioritization

Leadership through influence

Education

Bachelor's degree

MBA or postgraduate qualification

Job description

Iovance Biotherapeutics, Inc. seeks a Commercial Lead, Australia to establish and scale the Australian market for AMTAGVI and Proleukin.

You will own the commercial strategy, drive revenue and profitability, and lead the full sales cycle from market development to patient infusion. You will build executive relationships with treatment centres and authorities, ensure regulatory and quality standards, and coordinate cross-functionally to accelerate market access.